logo

Aripiprazole and Autism Ranking: Mildly Hazardous Very strong positive evidence

Ongoing Research

  • The Cambridge Health Alliance and Bristol-Myers Squibb are running one trial into the efficacy, safety and tolerability of aripiprazole in children with ASD. Clinical Trials Gov Ref: NCT00308074. For more details, please see An open-label trial of aripiprazole in autism spectrum disorders Full Item(Open in New Window).
  • Drexel University is running one trial into the use of aripiprazole. Clinical Trials Gov Ref: NCT00208533. For more details, please see Aripiprazole in children with autism: A pilot study  Full Item(Open in New Window).
  • The National Institute of Mental Health is running  a trial into the use of Aripiprazole. For more details, please see Evaluating the effectiveness of aripiprazole and D-cycloserine to treat symptoms associated with autism Clinical Trials Gov Ref: NCT00198107 Full Item(Open in New Window).
  • The University of Medicine and Dentistry New Jersey is running one trial into the use of aripiprazole. Clinical Trials Gov Ref: NCT00468130. For more details, please see Efficacy of aripiprazole versus placebo in the reduction of aggressive and aberrant behavior in autistic children Full Item(Open in New Window).
Updated
17 Jun 2022
Last Review
01 Jul 2018
Next Review
01 Mar 2024